Merck & Co., Inc. (MRK)
NYSE · Healthcare
Merck & Co., Inc. Shareholder Equity 2007–2025
Merck & Co., Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Merck & Co., Inc. shareholder equity as of December 31, 2025: 52.61B, a 13.59% increase year-over-year.
- Merck & Co., Inc. shareholder equity for 2025 were 52.61B, a 13.59% increase from 2024.
- Merck & Co., Inc. shareholder equity for 2024 were 46.31B, a 23.24% increase from 2023.
- Merck & Co., Inc. shareholder equity for 2023 were 37.58B, a 18.29% decrease from 2022.
- Merck & Co., Inc. shareholder equity for 2022 were 45.99B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Merck & Co., Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $52,606 |
| 2024 | $46,313 |
| 2023 | $37,581 |
| 2022 | $45,991 |
| 2021 | $38,184 |
| 2020 | $25,317 |
| 2019 | $25,907 |
| 2018 | $26,701 |
| 2017 | $34,336 |
| 2016 | $40,088 |
| 2010 | $54,376 |
| 2009 | $59,058 |
| 2008 | $18,758 |
Merck & Co. Inc. Shareholder Equity — FAQ
Merck & Co. Inc. (MRK) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRK's shareholder equity history?
The chart and table above show Merck & Co. Inc.'s shareholder equity by year and by quarter, including the growth rate.